nivolumab,ipilimumab,cabozantinib,sunitinib
pfizer,bms
['check,mate,9er', 'cabo ', 'nivo', 'sunitinib', 'rcc,(-irccs),(-srcc),(-urcc)']
pros from checkmate 9er (nivo/cab vs sunitinib mrcc): hrqol with nivo/cabo maximized in imdc int/poor risk, but not fav risk se in nivo/cabo arm irrespective of imdc risk (or:0.50) time to confirmed deterioration improved w/ nivo/cab in int/poor risk only #asco23 
MD, MSc | @UofTUrology @SUO_YUO Fellow & @IHPMEUofT CEHCR PhD| Previously: @MCG_Urology and @AUB_Lebanon 🇱🇧